Cargando…
Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898883/ https://www.ncbi.nlm.nih.gov/pubmed/31539052 http://dx.doi.org/10.1093/eurheartj/ehz657 |
_version_ | 1783477048140890112 |
---|---|
author | von Oertzen, Tim J Trinka, Eugen Bornstein, Natan M |
author_facet | von Oertzen, Tim J Trinka, Eugen Bornstein, Natan M |
author_sort | von Oertzen, Tim J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6898883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68988832019-12-12 Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination von Oertzen, Tim J Trinka, Eugen Bornstein, Natan M Eur Heart J Discussion Forum Oxford University Press 2019-12-07 2019-09-20 /pmc/articles/PMC6898883/ /pubmed/31539052 http://dx.doi.org/10.1093/eurheartj/ehz657 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Discussion Forum von Oertzen, Tim J Trinka, Eugen Bornstein, Natan M Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title | Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title_full | Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title_fullStr | Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title_full_unstemmed | Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title_short | Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
title_sort | levetiracetam and non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination |
topic | Discussion Forum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898883/ https://www.ncbi.nlm.nih.gov/pubmed/31539052 http://dx.doi.org/10.1093/eurheartj/ehz657 |
work_keys_str_mv | AT vonoertzentimj levetiracetamandnonvitaminkantagonistoralanticoagulantsinpatientswithatrialfibrillationandepilepsyareasonablecombination AT trinkaeugen levetiracetamandnonvitaminkantagonistoralanticoagulantsinpatientswithatrialfibrillationandepilepsyareasonablecombination AT bornsteinnatanm levetiracetamandnonvitaminkantagonistoralanticoagulantsinpatientswithatrialfibrillationandepilepsyareasonablecombination |